Testing effectiveness (Phase 2)UnknownNCT04888663
What this trial is testing
Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study)
Who this might be right for
Recurrent/Metastatic Gastric Cancer
Yonsei University 50